Delivering robust and meaningful data in support of an ever-increasing demand on tissue-based biomarker evaluations is critical to improving decision making in clinical R&D. To realise these requirements, it is vitally important to implement quality standards...
Home /
5 Ways Quantitative Digital Pathology Can Add Value to Immuno-Oncology R&D
Quantifying the number, type and distribution of immune cells in oncology tissue is key to obtaining a greater understanding of the actions of immunotherapies as part of immuno-oncology research. With the advent of advanced quantitative digital histopathology...
Use of histology image analysis to aid selection of oncology xenograft models for drug development
The development of new oncology therapies is routinely supported through the use of various xenograft models. Identifying the most suitable models for use in pre-clinical oncology programmes is key to establishing a successful translational R&D strategy. The...
Microscope Slide Scanning
Microscope slide scanning to produce digital histology images is a recent technology which is of interest to both histologists and pathologists. Microscope slide scanning to produce digital images is routinely used in various teaching organisations, however its...